Scott D Berkowitz

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial.

Khalid Yusoff, Frederick M. Costello, Martin O'Donnell, 2017, Lancet.

Oral rivaroxaban for symptomatic venous thromboembolism.

Bruce L Davidson, Giancarlo Agnelli, Sebastian Schellong, 2010, The New England journal of medicine.